GTCR-backed Corza Medical to sell its biosurgery business unit to EQT

Corza Medical, a medical technology company, is selling its biosurgery business unit to EQT. Corza Medical is headquartered in Boulder, Colorado. This divestiture comes after its formation in 2019, when GTCR partnered with Greg Lucier to establish the company. The specific terms of the agreement, including the financial value of the transaction, were not disclosed in the announcement. Ultimately, GTCR will continue to own and operate the remaining segments of Corza Medical’s business. This includes its operations in wound closure, ophthalmology, and biomedical textiles. The decision to sell the biosurgery unit indicates a strategic realignment for Corza Medical and its private equity backer. The transaction allows Corza Medical to streamline its operations and potentially focus resources on its core business units. This specialization might lead to enhanced development and market penetration in its retained sectors of wound closure, ophthalmology, and biomedical textiles. This move by a private equity-backed entity to divest a specific business unit suggests a broader trend within the healthcare sector towards optimizing portfolios for growth and operational efficiency. It highlights how private equity firms may strategically carve out segments of their portfolio companies to maximize value and sharpen corporate focus in a competitive market.